Bio

My goal is to fully integrate Genetics and Genomics into the clinical space- to change our approach to cancer care by targeting cancer disease mechanisms to improve patient outcomes. Clinical genomics, through the use of new ''Next-Generation'' sequencing technologies (NGS) is making this a reality. Our current focus is on bringing expert clinical interpretation to complex genomics data as a professional service. Current clinical laboratory Next-Gen sequencing test results are simply too complex for most oncologists to fully comprehend. We seek to bridge this gap and provide them with a thorough explanation of the biology of their patient's tumor, as well as relevant targeted treatment options and clinical trials. I have expertise in NGS clinical and research pipleline development, as well as working with informatics teams to build clinically-relevant systems for complex data annotation and interpretation. I am board certified in Anatomic Pathology and Molecular Genetic Pathology, and have a Ph.D. in Human Molecular Genetics.